Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents

Neuroscience Letters

Volumn 418, Issue 1, 2007, Pages 106-110

  Yang, Jir Jei ^a,b   Yin, Jiu Haw ^c,d   Yang, Ding I ^e  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

BCNU; Brain tumor; Carbamoylation; Chloroethylation; Glioblastoma multiforme

Indexed keywords

1,2 BIS(METHYLSULFONYL) 1 (2 CHLOROETHYL)HYDRAZINE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ALKYLATING AGENT; ETHYLNITROSOUREA; MESYLIC ACID METHYL ESTER; METHYLNITROSOUREA; NITROPRUSSIDE SODIUM; S NITROSOGLUTATHIONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; GLIOMA; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; DRUG SYNERGISM; GLIOMA; NITRIC OXIDE DONORS; RATS;

EID: 34247092813     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.03.011     Document Type: Article

References (22)

1. Jochheim C.M., and Baillie T.A. Selective and irreversible inhibition of glutathione reductase in vitro by carbamate thioester conjugates of methyl isocyanate. Biochem. Pharmacol. 47 (1994) 1197-1206
2. Ju T.C., Chen S.D., Liu C.C., and Yang D.I. Protective effects of S-nitrosoglutathione against amyloid beta-peptide neurotoxicity. Free Radic. Biol. Med. 38 (2005) 938-949
3. Ju T.C., Yang Y.T., and Yang D.I. Protective effects of S-nitrosoglutathione against neurotoxicity of 3-nitropropionic acid in rat. Neurosci. Lett. 362 (2004) 226-231
4. Kaina B., and Christmann M. DNA repair in resistance to alkylating anticancer drugs. Int. J. Clin. Pharmacol. Ther. 40 (2002) 354-367
5. Kang Y.C., Kim P.K., Choi B.M., Chung H.T., Ha K.S., Kwon Y.G., and Kim Y.M. Regulation of programmed cell death in neuronal cells by nitric oxide. In Vivo 18 (2004) 367-376
6. Khan M., Sekhon B., Giri S., Jatana M., Gilg A.G., Ayasolla K., Elango C., Singh A.K., and Singh I. S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J. Cereb. Blood Flow Metab. 25 (2005) 177-192
7. Kim P.K., Kwon Y.G., Chung H.T., and Kim Y.M. Regulation of caspases by nitric oxide. Ann. N.Y. Acad. Sci. 962 (2002) 42-52
8. Liu L., Xu-Welliver M., Kanugula S., and Pegg A.E. Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide. Cancer Res. 62 (2002) 3037-3043
9. Mohr S., Hallak H., de Boitte A., Lapetina E.G., and Brune B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 274 (1999) 9427-9430
10. Nutt C.L., Noble M., Chambers A.F., and Cairncross J.G. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res. 60 (2000) 4812-4818
11. Paoletti P. Therapeutic strategy for central nervous system tumors: present status, criticism and potential. J. Neurosurg. Sci. 28 (1984) 51-60
12. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50 (1990) 6119-6129
13. Penketh P.G., Shyam K., and Sartorelli A.C. Comparison of DNA lesions produced by tumor-inhibitory 1,2-bis(sulfonyl)hydrazines and chloroethylnitrosoureas. Biochem. Pharmacol. 59 (2000) 283-291
14. Rolhion C., Penault-Llorca F., Kemeny J.L., Kwiatkowski F., Lemaire J.J., Chollet P., Finat-Duclos F., and Verrelle P. O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation. Int. J. Cancer 84 (1999) 416-420
15. Sheu F.S., Zhu W., and Fung P.C. Direct observation of trapping and release of nitric oxide by glutathione and cysteine with electron paramagnetic resonance spectroscopy. Biophys. J. 78 (2000) 1216-1226
16. Shyam K., Penketh P.G., Loomis R.H., Rose W.C., and Sartorelli A.C. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-hydrazines. J. Med. Chem. 39 (1996) 796-801
17. 6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea. Biochemistry 35 (1996) 1328-1334
18. Wheeler G.P., Bowdon B.J., Grimsley J.A., and Lloyd H.H. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas. Cancer Res. 34 (1974) 194-200
19. Yang D.I., Chen S., Ezekiel U.R., Xu J., Wu Y., and Hsu C.Y. Antisense RNA to inducible nitric oxide synthase reduces cytokine-mediated brain endothelial cell death. Ann. N.Y. Acad. Sci. 1042 (2005) 439-447
20. Yang D.I., Chen S.D., Yang Y.T., Ju T.C., Xu J.M., and Hsu C.Y. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1. Br. J. Pharmacol. 141 (2004) 988-996
21. Yang D.I., Yin J.H., Ju T.C., Chen L.S., and Hsu C.Y. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione. Free Radic. Biol. Med. 36 (2004) 1317-1328
22. Yin J.H., Yang D.I., Chou H., Thompson E.M., Xu J., and Hsu C.Y. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in C6 glioma cells. J. Pharmacol. Exp. Ther. 297 (2001) 308-315